Literature DB >> 2986587

Characterization of a human hepatic receptor for high density lipoproteins.

J M Hoeg, S J Demosky, S B Edge, R E Gregg, J C Osborne, H B Brewer.   

Abstract

Characterization of the membrane receptor for the low density lipoproteins (LDL) has led to insights into cellular receptor physiology as well as mammalian lipid transport. Result with LDL have stimulated the search for specific receptors for other plasma lipoproteins. Receptors for high density lipoproteins (HDL) have been identified in human fibroblasts and smooth muscle cells. Specificity for this receptor has been difficult to define since normal HDL contains several apolipoproteins, and particles containing apolipoproteins B and E have been shown to compete for HDL binding. In the present study, we demonstrate that HDL isolated from a patient devoid of apolipoprotein E was bound specifically by human hepatic membranes. This binding reached saturation within 2 hours and was EDTA-resistant. Assuming a single receptor model, we found that 2.9 x 10(15) receptors/mg membrane protein bound with an affinity KD = 3.5 x 10(-7) M at 0 to 4 degrees C and KD = 1.9 x 10(-7) M at 37 degrees C. The binding was effectively competed with intact HDL3, with HDL3 that had undergone selective arginine and lysine residue modification, and with antibodies to apolipoproteins A-I and A-II. However, LDL, asialofetuin, and HDL3 which had undergone tyrosine modification by nitration, and anti-apolipoprotein B did not compete with apo A-I HDL binding. In contrast to LDL binding, the human hepatoma cell line, HEPG2, increased HDL binding with cholesterol loading that was specific for HDL3. Thus, hepatic tissue can modulate its recognition of HDL. Finally, hepatic membranes from a patient lacking normal hepatic LDL receptors bound apo A-I HDL normally. These data indicate that a saturable, specific regulatable receptor for apo E-free HDL is present in human liver.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2986587     DOI: 10.1161/01.atv.5.3.228

Source DB:  PubMed          Journal:  Arteriosclerosis        ISSN: 0276-5047


  12 in total

Review 1.  Metabolism of high density lipoproteins in liver cancer.

Authors:  Jing-Ting Jiang; Ning Xu; Chang-Ping Wu
Journal:  World J Gastroenterol       Date:  2007-06-21       Impact factor: 5.742

2.  The role of apoproteins AI and AII in binding of high-density lipoprotein3 to membranes derived from bovine aortic endothelial cells.

Authors:  P K Vadiveloo; N H Fidge
Journal:  Biochem J       Date:  1992-05-15       Impact factor: 3.857

3.  Purification and characterization of two high-density-lipoprotein-binding proteins from rat and human liver.

Authors:  M Tozuka; N Fidge
Journal:  Biochem J       Date:  1989-07-01       Impact factor: 3.857

4.  Further cellular investigation of the human hepatoblastoma-derived cell line HepG2: morphology and immunocytochemical studies of hepatic-secreted proteins.

Authors:  M E Bouma; E Rogier; N Verthier; C Labarre; G Feldmann
Journal:  In Vitro Cell Dev Biol       Date:  1989-03

5.  Cholesterol feeding to rats does not modulate the expression of binding sites for HDL on liver membranes.

Authors:  F M Maggi; A L Catapano
Journal:  Experientia       Date:  1986-10-15

Review 6.  Reverse cholesterol transport: from classical view to new insights.

Authors:  Astrid-E van der Velde
Journal:  World J Gastroenterol       Date:  2010-12-21       Impact factor: 5.742

7.  Monoclonal antibodies to human apolipoprotein AI: probing the putative receptor binding domain of apolipoprotein AI.

Authors:  C M Allan; N H Fidge; J R Morrison; J Kanellos
Journal:  Biochem J       Date:  1993-03-01       Impact factor: 3.857

8.  Net transport of cholesterol from cells of the human EA.hy 926 endothelial cell line to high density lipoproteins.

Authors:  E P Kilsdonk; A N Dorsman; A van Tol
Journal:  Experientia       Date:  1993-07-05

Review 9.  Lipids changes in liver cancer.

Authors:  Jing-Ting Jiang; Ning Xu; Xiao-Ying Zhang; Chang-Ping Wu
Journal:  J Zhejiang Univ Sci B       Date:  2007-06       Impact factor: 3.066

10.  Interaction in vivo and in vitro of apolipoprotein E-free high-density lipoprotein with parenchymal, endothelial and Kupffer cells from rat liver.

Authors:  D Schouten; M Kleinherenbrink-Stins; A Brouwer; D L Knook; T J Van Berkel
Journal:  Biochem J       Date:  1988-12-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.